Live Breaking News & Updates on Elixir health public relations

Stay informed with the latest breaking news from Elixir health public relations on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Elixir health public relations and stay connected to the pulse of your community

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer's Disease and Biomarker Endpoints

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer's Disease and Biomarker Endpoints
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sweden , Boston , Massachusetts , United-states , Gothenburg , Vastra-gotalands-lan , Americans , Melyssa-weible , Bruce-mackle , Mccroryj-gerontol , K-biovie-inc , World-health-organization

BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation

BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sweden , United-states , Gothenburg , Vastra-gotalands-lan , Boston , Massachusetts , Americans , Bruce-mackle , Melyssa-weible , Elixir-health-public-relations , International-nonproprietary-names , Lifesci-advisors

Reaction Biology Launches Innovative Offering Within Its Kinase Testing Platform and Presents New Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

/PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry-leading provider of drug discovery and development services, today announced that...

San-diego , California , United-states , Heidelberg , Baden-wüberg , Germany , American , Johnh-johnson , Haiching-ma , Lindsay-rocco , Good-laboratory-practice , American-association-for-cancer-research

BioVie Announces Pipeline Update and Near-Term Clinical Priorities

Recently completed financing provides sufficient funds for near-term Parkinson’s Disease priority Plans for Phase 2b trial of NE3107 as first-line monotherapy for Parkinson’s Disease being finalized with targeted launch late-summer 2024 Once-daily NE3107 formulation expected to be available early 2025 and will be used for Phase 3 trial in Alzheimer’s Disease Phase 3 trial for BIV201 in preparation following FDA feedback with guidance on development path; program delayed pending partnership fundi

Denmark , Portugal , United-states , Copenhagen , Køavn- , Lisbon , Lisboa , Gothenburg , Vastra-gotalands-lan , Sweden , Americans , Bruce-mackle

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

~ Fourth Quarter 2023 Net Revenues of Approximately $9.2 to $9.7 Million ~ ~ Company Expects to Report 2023 Fourth Quarter and Audited Full-Year Results on or about March 26, 2024 ~ RESEARCH...

Oregon , United-states , Robert-andrade , Lindsay-rocco , Exchange-commission , Nasdaq , Fennec-pharmaceuticals-inc , Elixir-health-public-relations , Company-expects-to , Clinical-oncology-group , Drug-administration , Oregon-health

Mineralys Therapeutics Announces $120 Million Private Placement Financing

Mineralys Therapeutics Announces $120 Million Private Placement Financing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Radnor , Pennsylvania , Tom-weible , Catalys-pacific , Mineralys-therapeutics-inc , Exchange-commission , Elixir-health-public-relations , Nasdaq , Therapeutics-announces , Private-placement , Venrock-healthcare-capital-partners

FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 -- Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has...

Oregon , United-states , Lindsay-rocco , Robert-andrade , Oregon-health , Office-of-communications , Science-university , Elixir-health-public-relations , Nasdaq , Fennec-pharmaceuticals , Fennec-pharmaceuticals-inc , Drug-administration

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Radnor , Pennsylvania , United-states , New-york , Catalys-pacific , Tom-weible , Jon-congleton , Mineralys-therapeutics-inc , Twitter , Elixir-health-public-relations , Nasdaq , Guggenheim-securities

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

RADNOR, Pa., Jan. 29, 2024 -- Mineralys Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other...

Radnor , Pennsylvania , United-states , New-york , Tom-weible , Catalys-pacific , Jon-congleton , Globenewswire-inc , Elixir-health-public-relations , Twitter , Nasdaq , Mineralys-therapeutics-inc

Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer

RADNOR, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused o...

South-korea , Seoul , Soult-ukpyolsi , United-states , Radnor , Pennsylvania , Minji-kim , Tom-weible , Catalys-pacific , Tanabe-pharma , Jon-congleton , Adam-levy